- The Oncology Institute to Participate at Upcoming Investor Conferences
- The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference
- The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance
- The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
- The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
- Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute
- The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
- The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
- MaxHealth & The Oncology Institute Expand Value-Based Care Partnership
- The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
More ▼
Key statistics
On Wednesday, Oncology Institute Inc (TOI:NAQ) closed at 0.4879, 19.88% above the 52 week low of 0.407 set on Jun 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.4698 |
---|---|
High | 0.4898 |
Low | 0.4599 |
Bid | 0.485 |
Offer | 0.50 |
Previous close | 0.46 |
Average volume | 64.61k |
---|---|
Shares outstanding | 74.44m |
Free float | 50.87m |
P/E (TTM) | -- |
Market cap | 36.32m USD |
EPS (TTM) | -0.8066 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 17:58 BST.
More ▼